IBS in America | A Comprehensive Survey
THE “IBS IN AMERICA” SURVEY was commissioned by the American Gastroenterological Association (AGA) and conducted with the financial support of Ironwood Pharmaceuticals, Inc. and Allergan plc. Online surveys were conducted by GfK, Sept. 14 through Oct. 29, 2015. In total 3,254 IBS sufferers, both diagnosed and undiagnosed, as well as 302 physicians who treat IBS patients – 151 primary care physicians and 151 gastroenterologists – were interviewed.
The survey demonstrated that the symptoms of IBS are often so bothersome and unpredictable that they interfere with daily life at home, work and school, and many people suffer for years before seeing a doctor.
- When physicians were asked about what is most lacking in the treatment of IBS, the number one answer was the lack of biomarkers to guide treatment